Newsfeeds Archive - Spark Newswire

4 minute read

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

April 29, 1:04 PM

Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday’s session after the company announced that it…

ADXN

2 minute read

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday

By Avi Kapoor

April 29, 10:47 AM

U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday. Shares of Tesla, Inc.…

ALB

5 minute read

Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Avi Kapoor

April 26, 1:56 PM

Shares of Aon plc (NYSE:AON) fell sharply during Friday’s session after the company reported worse-than-expected quarterly financial results.…

ACCD

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

April 26, 12:31 PM

Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 61.4% to $1.17 during Friday’s regular session. The company’s market cap stands…

ACCD

3 minute read

Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday

By Avi Kapoor

April 26, 10:45 AM

U.S. stocks were higher, with the Dow Jones jumping over 150 points on Friday. Shares of Skechers U.S.A.,…

2 minute read

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?

By Vandana Singh

April 24, 2:29 PM

Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN-978 potential for autoimmune diseases, particularly systemic lupus erythematosus.

AMGN

2 minute read

Uncategorized

Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday

By Avi Kapoor

April 24, 11:19 AM

U.S. stocks were mixed, with the Dow Jones falling over 100 points on Wednesday. Shares of Hilton Worldwide…

BILI

2 minute read

Cullinan Therapeutics To Present Clinical Data From Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, As Monotherapy And In Combination With A Checkpoint Inhibitor In Patients With Advanced Solid Tumors At ASCO 2024

By Benzinga Newsdesk

April 24, 10:10 AM

Cullinan Therapeutics, Inc. (NASDAQ:CGEM), a biopharmaceutical company focused on modality-agnostic targeted therapies, today announced that clinical data from its Phase 1 trial of CLN-619 in patients with advanced solid

CGEM